openPR Logo
Press release

The Global Drug Eluting Balloon Catheter Market Is Expected To Be Worth US$ 5.2 Bn By The End Of 2031

11-10-2022 07:25 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Drug Eluting Balloon Catheter Market

Drug Eluting Balloon Catheter Market

Healthcare infrastructure has seem some major changes over the past decade as technology proliferation increased and research on healthcare has also seen a substantial boom. Rising obesity, increasing geriatric population, and growing prevalence of coronary artery diseases are some of the factors propelling demand for drug eluting balloon catheters. When stents are used with a balloon catheter it is called a balloon expandable stent, which differs from self-expandable stents, and these are normally made from nitinol alloy.

Adoption of angioplasty balloons for patients who do not benefit from percutaneous coronary intervention (PCI) is also favouring growth of the drug eluting balloon (DEB) catheter market. Increased support from governments and other institutions backing research and granting funding to further develop drug eluting balloon catheters is being witnessed.

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—–๐—ผ๐—ฝ๐˜† ๐—ผ๐—ณ ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:https://www.factmr.com/connectus/sample?flag=S&rep_id=146

๐—ช๐—ต๐—ฎ๐˜ ๐—ถ๐˜€ ๐˜๐—ต๐—ฒ ๐—ข๐˜‚๐˜๐—น๐—ผ๐—ผ๐—ธ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐—ฃ๐—ฒ๐—ฟ๐—ถ๐—ฝ๐—ต๐—ฒ๐—ฟ๐—ฎ๐—น ๐—ฉ๐—ฎ๐˜€๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐——๐—˜๐—• ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜?

Usage of drug eluting devices is majorly associated with cardiac conditions, and these are used to reduce the rate of restenosis. The peripheral drug-coated balloon catheter market is poised to rise at a steady CAGR over the next ten years. Use of drug-eluting balloon catheters for peripheral artery procedures is anticipated to increase as their benefits are realized and procedures become more affordable.
Under the indication segment, demand for coronary artery disease drug eluting balloon catheters is anticipated to account for nearly 80% market share in terms of value. Despite minimal market share, demand for peripheral vascular disease drug-eluting balloon catheters is anticipated to rise at a steady CAGR over the forecast period.
As more angioplasty balloons are being researched and developed, it is estimated that sales of peripheral drug-coated balloon catheters will also see an upward trend.

๐—–๐—ข๐—ฉ๐—œ๐——-๐Ÿญ๐Ÿต ๐—œ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜ ๐—ผ๐—ป ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

The COVID-19 pandemic massively affected healthcare infrastructure and how it was handled. Treatment for every disease became secondary as the focus was only on combating coronavirus. The COVID-19 pandemic affected research & development related to drug eluting balloon catheters and caused major disruptions in demand and supply chains.
However, in the post-pandemic era, demand for drug eluting balloon catheters is anticipated to see rapid rise. Even though the pandemic caused a major drop in sales, the market is expected to recover the losses over the coming years as research speeds up.

๐—ช๐—ต๐—ฎ๐˜ ๐—ถ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ข๐˜‚๐˜๐—น๐—ผ๐—ผ๐—ธ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐——๐—ฟ๐˜‚๐—ด ๐—˜๐—น๐˜‚๐˜๐—ถ๐—ป๐—ด ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜?

This research details the global drug eluting balloon catheter industry landscape across the regions of North America, Latin America, Europe, APAC, and MEA.
Europe dominates the market and is anticipated to continue its domination throughout the forecast period. The U.K. is anticipated to lead the European market, surging at a stellar CAGR of around 20%.
North America is anticipated to be the second-largest market. The market in Asia is anticipated to rise at the fastest CAGR through the forecast period. India and China are anticipated to lead demand in the APAC region.
Adoption of drug eluting balloon catheters in MEA is expected to pick up pace as healthcare infrastructure develops across the region.

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€:https://www.factmr.com/connectus/sample?flag=RC&rep_id=146

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

Research in the drug eluting balloon catheter space by key players is anticipated bolster development and sales of more precise and efficient drug eluting balloon catheters.
โ€ข In February 2021, L2Mtech GmbH was awarded its first CE mark on six products. This marks a milestone in the company's history and proves the efficacy and safety of its innovative cardiovascular and endovascular applications. The company is planning to commercially launch the products with the CE mark recognition.
โ€ข In June 2020, iVascular SLU, a medical device company, announced the global launch of its novel coronary artery drug-coated balloon. The product - Essential Pro - has several improvements from its predecessor.
โ€ข In March 2021, MedAlliance announced that it had received FDA approval for its drug-eluting coronary balloon. The product is called the Selution SLR sustained limus release drug-eluting balloon catheter. It received a go-ahead for its design, which improved luminal diameter in individuals affected with atherosclerotic lesions.

๐—ž๐—ฒ๐˜† ๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ถ๐—น๐—ฒ๐—ฑ:
โ€ข Cardionovum GmbH
โ€ข Cook Medical INC
โ€ข Cordis Corporation
โ€ข Abbott Laboratories
โ€ข Meril Life Sciences Pvt Ltd
โ€ข Jotech GmbH
โ€ข MicroPort Scientific Corporation
โ€ข Terumo Corporation
โ€ข Boston Scientific Corporation

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ผ๐—ณ ๐——๐—ฟ๐˜‚๐—ด ๐—˜๐—น๐˜‚๐˜๐—ถ๐—ป๐—ด ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ฆ๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐˜†๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ง๐—ฎ๐˜…๐—ผ๐—ป๐—ผ๐—บ๐˜†

By Indication:
โ€ข Coronary Artery Disease Drug Eluting Balloon Catheters
โ€ข Peripheral Vascular Disease Drug Eluting Balloon Catheters

By End User:
โ€ข Hospitals
โ€ข Ambulatory Surgical Centers
โ€ข Cardiac Catheterization Laboratories

By Raw Material:
โ€ข Polyurethane Drug Eluting Balloon Catheters
โ€ข Nylon Drug Eluting Balloon Catheters
โ€ข Others

๐—™๐—ผ๐—ฟ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€:

https://www.prnewswire.com/news-releases/growing-need-for-bopp-metallized-films-to-create-us-3-72-bn-opportunity-by-2032--301571941.html

https://www.prnewswire.com/news-releases/magnesium-chloride-market-to-exceed-us-2-74-bn-by-2032-as-application-in-pharmaceutical-and-food--beverage-sectors-rises-301572903.html

https://www.prnewswire.com/news-releases/booming-motorsport-industry-to-steer-lap-timers-market-past-us-345-mn-by-2032-301573991.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.co

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Drug Eluting Balloon Catheter Market Is Expected To Be Worth US$ 5.2 Bn By The End Of 2031 here

News-ID: 2802666 • Views: โ€ฆ

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโ€ฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โ€ฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโ€ฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโ€ฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โ€ฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโ€ฆ

All 5 Releases


More Releases for Catheter

Midline Catheter Market
The midline catheter market plays a crucial role in healthcare, providing a safer and more effective means for intravenous (IV) therapies. Midline catheters are long, thin, flexible tubes that are inserted into a patient's veins, typically for periods ranging from a few days to a few weeks. They offer a minimally invasive alternative for administering medications, fluids, and nutrients directly into the bloodstream without the need for repeated needle sticks.โ€ฆ
Catheter Stabilization Devices Market
The "Catheter Stabilization Devices Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.ย  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Catheter Stabilization Devices Market, 2024-2031 Verified Market Research's most recent report, "Catheter Stabilization Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," providesโ€ฆ
Catheter Stabilization Devices Market: Enhancing Patient Safety and Care through โ€ฆ
The Catheter Stabilization Devices Market occupies a pivotal position in the healthcare industry, providing essential solutions for securing catheters and enhancing patient care. As indwelling catheters become integral to various medical procedures and treatment protocols, the need for effective stabilization and securement is paramount. This market addresses this crucial requirement by offering a diverse range of devices designed to prevent catheter-related complications, including dislodgement and infection. ๐—ง๐—ผ ๐—ฎ๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€ ๐˜๐—ต๐—ฒ ๐—ณ๐˜‚๐—น๐—น ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜โ€ฆ
Catheter Introducer Sheaths Market - Safeguarding Vascular Health: Advanced Shea โ€ฆ
Newark, New Castle, USA: The "Catheter Introducer Sheaths Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Catheter Introducer Sheaths Market: https://www.growthplusreports.com/report/catheter-introducer-sheaths-market/8787 This latest report researches the industry structure,โ€ฆ
Catheter-related Blood Infections Market - Empowering Catheter Safety: Leading t โ€ฆ
Newark, New Castle, USA: The "Catheter-related Blood Infections Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Catheter-related Blood Infections Market: https://www.growthplusreports.com/report/catheterrelated-blood-infections-market/8671 This latest report researches the industry structure,โ€ฆ
Exclusive Report on Catheter Stabilization Devices Catheter Securement Devices M โ€ฆ
According to the study published by Evolve business intelligence, โ€œThe global Catheter Stabilization Devices Catheter Securement Devices market size is expected to reach $ Billion by 2028 growing at the CAGR of 15% from 2021 to 2028. The report provides the reader with a deep-dive understanding of business opportunities, competitor analysis, market size and forecast, go-to-market strategy, and market share. After evaluating the next-gen business analytic report, the reader isโ€ฆ